Cheng D - Search Results

1

Therapeutic inhibition of MPO stabilizes pre-existing high risk atherosclerotic plaque.

Chen W, Tumanov S, Kong SMY, Cheng D, Michaëlsson E, Bongers A, Power C, Ayer A, Stocker R. Chen W, et al. Among authors: cheng d. Redox Biol. 2022 Dec;58:102532. doi: 10.1016/j.redox.2022.102532. Epub 2022 Nov 5. Redox Biol. 2022. PMID: 36375379 Free PMC article.

2

Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.

Rashid I, Maghzal GJ, Chen YC, Cheng D, Talib J, Newington D, Ren M, Vajandar SK, Searle A, Maluenda A, Lindstedt EL, Jabbour A, Kettle AJ, Bongers A, Power C, Michaëlsson E, Peter K, Stocker R. Rashid I, et al. Among authors: cheng d. Eur Heart J. 2018 Sep 14;39(35):3301-3310. doi: 10.1093/eurheartj/ehy419. Eur Heart J. 2018. PMID: 30219874

3

Inhibition of MPO (Myeloperoxidase) Attenuates Endothelial Dysfunction in Mouse Models of Vascular Inflammation and Atherosclerosis.

Cheng D, Talib J, Stanley CP, Rashid I, Michaëlsson E, Lindstedt EL, Croft KD, Kettle AJ, Maghzal GJ, Stocker R. Cheng D, et al. Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1448-1457. doi: 10.1161/ATVBAHA.119.312725. Epub 2019 May 2. Arterioscler Thromb Vasc Biol. 2019. PMID: 31043077 Free article.

4

Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.

Talib J, Maghzal GJ, Cheng D, Stocker R. Talib J, et al. Among authors: cheng d. Free Radic Biol Med. 2016 Aug;97:124-135. doi: 10.1016/j.freeradbiomed.2016.05.004. Epub 2016 May 13. Free Radic Biol Med. 2016. PMID: 27184954

5

Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity.

Wang C, Cheng D, Jalali Motlagh N, Kuellenberg EG, Wojtkiewicz GR, Schmidt SP, Stocker R, Chen JW. Wang C, et al. Among authors: cheng d. J Med Chem. 2021 May 13;64(9):5874-5885. doi: 10.1021/acs.jmedchem.1c00038. Epub 2021 May 4. J Med Chem. 2021. PMID: 33945286 Free PMC article.

6

Clinical Relevance of Biomarkers of Oxidative Stress.

Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, Taylor EL, Oettrich J, Ruskovska T, Gasparovic AC, Cuadrado A, Weber D, Poulsen HE, Grune T, Schmidt HH, Ghezzi P. Frijhoff J, et al. Among authors: cheng d. Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70. doi: 10.1089/ars.2015.6317. Epub 2015 Oct 26. Antioxid Redox Signal. 2015. PMID: 26415143 Free PMC article. Review.

7

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.

Karl T, Garner B, Cheng D. Karl T, et al. Among authors: cheng d. Behav Pharmacol. 2017 Apr;28(2 and 3-Spec Issue):142-160. doi: 10.1097/FBP.0000000000000247. Behav Pharmacol. 2017. PMID: 27471947 Review.

8

Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.

Kim WS, Li H, Ruberu K, Chan S, Elliott DA, Low JK, Cheng D, Karl T, Garner B. Kim WS, et al. Among authors: cheng d. J Neurosci. 2013 Mar 6;33(10):4387-94. doi: 10.1523/JNEUROSCI.4165-12.2013. J Neurosci. 2013. PMID: 23467355 Free PMC article.

9

Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice.

Cheng D, Low JK, Logge W, Garner B, Karl T. Cheng D, et al. Behav Brain Res. 2014 Mar 1;260:111-8. doi: 10.1016/j.bbr.2013.11.046. Epub 2013 Dec 4. Behav Brain Res. 2014. PMID: 24315833

10

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.

Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Cheng D, et al. J Alzheimers Dis. 2014;42(4):1383-96. doi: 10.3233/JAD-140921. J Alzheimers Dis. 2014. PMID: 25024347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,514 results

Search Page